Cartesian Therapeutics Files 8-K
Ticker: RNAC · Form: 8-K · Filed: Apr 8, 2025 · CIK: 1453687
| Field | Detail |
|---|---|
| Company | Cartesian Therapeutics, Inc. (RNAC) |
| Form Type | 8-K |
| Filed Date | Apr 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC Filing, Financials
TL;DR
Cartesian Therapeutics filed an 8-K, mostly routine stuff, check exhibits for details.
AI Summary
On April 8, 2025, Cartesian Therapeutics, Inc. filed an 8-K report. The filing primarily concerns financial statements and exhibits, along with other events and a Regulation FD disclosure. No specific new material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing indicates routine corporate reporting by Cartesian Therapeutics, Inc. to the SEC, providing updates on financial statements and other events.
Risk Assessment
Risk Level: low — The filing is a standard 8-K report with no immediate indication of significant new risks or material adverse events.
Key Players & Entities
- Cartesian Therapeutics, Inc. (company) — Registrant
- 001-37798 (company) — Commission File Number
- 26-1622110 (company) — IRS Employer Identification No.
- 7495 New Horizon Way, Frederick, MD 21703 (company) — Address of principal executive offices
- 301-348-8698 (company) — Registrant's telephone number
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on financial statements and exhibits, other events, and a Regulation FD disclosure for Cartesian Therapeutics, Inc.
When was this 8-K report filed?
This 8-K report was filed on April 8, 2025.
What is the exact name of the reporting company?
The exact name of the reporting company is Cartesian Therapeutics, Inc.
In which state was Cartesian Therapeutics, Inc. incorporated?
Cartesian Therapeutics, Inc. was incorporated in Delaware.
What is the company's principal executive office address?
The company's principal executive office is located at 7495 New Horizon Way, Frederick, MD 21703.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 8, 2025 regarding Cartesian Therapeutics, Inc. (RNAC).